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ABSTRACT 
 
Effects of Individualized Prescriptive Exercise Program on Selected Fitness Parameters 
and Fatigue of Acute Leukemia Patients Undergoing Treatment 
 
Anna Sanzhar 
 
(Under the direction of Dr. Claudio Battaglini) 
 
  
Although standard treatment improves survival for acute leukemia patients, 
development of treatment side effects is of major concern. Therefore, it is important to 
explore the impact of adjunct therapies, such as exercise, in mitigating treatment-related 
side effects. The primary purpose of this study was to examine the effects of exercise on 
selected fitness parameters and fatigue in acute leukemia patients undergoing treatment. 
A secondary purpose was to examine the relationship between changes in selected fitness 
parameters and fatigue. Ten patients with acute leukemia participated in this study. 
Exercise protocol included aerobic, resistance, and flexibility performed 3 times/week for 
6 weeks. Significant changes in cardiovascular endurance and overall fatigue (p = 0.009 
for both), with no changes in overall muscular endurance (p= 0.715) were observed. In 
conclusion, the results of this study suggest that administration of exercise during the 
leukemia treatment promotes improvement of cardiovascular endurance, maintenance of 
muscular endurance and reduction in fatigue levels. 
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CHAPTER I 
INTRODUCTION 
Leukemia is a group of blood cancers that affects bone marrow and results in 
uncontrolled accumulation of abnormal (malignant) blood cells.  The accumulation of 
malignant cells interferes with the body's production of normal blood cells and can result in 
severe anemia, decreased ability to fight infections and a predisposition to bleeding. 30% 
In most types of leukemia, the abnormal cells are white blood cells.  There are several 
types of leukemia that can be grouped in two ways.  Firstly, depending on the type of blood 
cells affected, leukemia can be Myelogenous (myeloid cells) or Lymphocytic (lymphoid 
cells).  Secondly, leukemia can be divided into acute (fast forming) or chronic (slow 
growing).  Acute leukemia is a rapidly progressing disease that results in the accumulation of 
immature, functionless cells in the marrow and blood.  Chronic leukemia progresses more 
slowly and allows greater number of more mature, functional cells to be made.  Acute types 
of leukemia are more dangerous and account for nearly 9 percent more of the cases than 
chronic types of leukemia (The Leukemia and Lymphoma Society, 2006).  This is one of the 
reasons why present study is focused on acute leukemia types. 
Acute leukemia affects both physiological and psychological health.  Anemia, nausea, 
infections and uncontrollable bleeding are common physiological side effects reported by 
leukemia statistics (The Leukemia and Lymphoma Society, 2006).  The diagnosis of 
leukemia, as any other cancer, often provokes a profound emotional response in the patient.  
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Anxiety, depression, stress, and fear are frequently reported to be usual reactions (Servaes et 
al., 2002).  Furthermore, pain, fatigue, and depression are the most common complains of all 
cancer patients undergoing chemotherapy (National Cancer Institute, 2006).   
Presently, there are approximately 10.1 million people in the United States with cancer 
history and about 208,080 of them are living with or in remission from leukemia (The 
Leukemia and Lymphoma Society, 2006).   National Cancer Institute reported 21,608 deaths 
from leukemia in United States in 2003.  In 2005, an estimated 34,810 new cases of leukemia 
were diagnosed with approximately 22,570 cases resulting in death (National Cancer 
Institute, 2006).  The incidence and mortality rates for all types of leukemia have not 
changed substantially over the last 30 years.  National Cancer Institute (2006) reported 
average annual incidence rate of 12.9 and mortality rate of 7.9 per 100,000 men and women 
for the period 1975-2003, comparing to 11.9 and 7.4 for 2003.   
Treatment for leukemia as for any other type of cancer is complex.  Standard treatment 
for leukemia usually involves either chemotherapy, or radiation therapy, or combination of 
both.  Most patients with leukemia are treated with chemotherapy.  Some also may have bone 
marrow transplantation.  Standard medical treatment has been proven to be effective in 
fighting most types of cancer and safe for patients (Leukemia and Lymphoma Society, 2006).  
Although standard treatment improves survival for individuals with all types of leukemia, the 
side effects can be significant (Leukemia and Lymphoma Society, 2006).  
 There is number of treatment strategies that are currently used to alleviate these side 
effects.  Most of them are based on medication and prescribed by a physician.  For example, 
Erythropoietin Alfa (Prednisone or Dexamethasone) is used to treat anemia, Methylphenidate 
is frequently prescribed to alleviate depression.  In addition to the prescribed treatment, many 
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patients will seek other remedies or treatments, sometimes called complementary or 
alternative therapies.  For cancers other than leukemia such as breast, stomach and prostate 
cancer exercise therapy has been shown as an alternative treatment strategy to cope with 
cancer treatment-related side effects (Courneya et al., 2003; Dimeo, 2001; Kolden et al., 
2002).   
Review of exercise intervention studies in cancer patients by Galvão and Newton (2005) 
has shown that majority of the studies suggest physiological and psychological benefits of 
regular exercise.  However, out of twenty-six studies only three included leukemia patients.  
Moreover, all three studies used different types of exercise intervention making them 
difficult to compare.  In the study by Dimeo et al. (2003) daily walking at intensity of 70% of 
maximal heart rate (MHR) was the only cardiovascular component of the exercise program.  
Another study by Cinningham et al. (1986) focused on resistance training at unspecified 
intensity 3-5 times a week.  Adamsen et al. (2006) performed the only study that used 
combination of resistance training, cycling and relaxation.  In Adamsen et al. study exercise 
was performed 4 times a week and included 3 sets of 5-8 repetitions at 85-95% of 1-RM, 
cycling at 60-100% of MHR and relaxation.  Out of all three studies the one by Adamsen et 
al. (2006) showed the greatest improvement in outcome measures: 32.5 % improvement in 
whole body strength, 16% improvement in maximal oxygen uptake (VO2max) and 
maintenance of quality of life.   
In present study exercise intervention program included a combination of cardiovascular, 
resistance, and flexibility exercises in order to provide the maximal benefits to the patients. 
There are very few studies that examined the effect of exercise on combating the side 
effects of leukemia treatment.  Moreover, to the knowledge of the author, no study has ever 
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been conducted at the hospital while acute leukemia patients were undergoing treatment.  
Since exercise has demonstrated to be a promising intervention in combating cancer 
treatment-related side effects in different cancer patients, it is plausible to believe that 
exercise benefits could also be attained in the leukemia population. 
Purpose of the Study 
The primary purpose of this study was to examine the effects of an individualized 
exercise prescription on selected physical fitness parameters and overall fatigue in acute 
leukemia patients undergoing chemotherapy (Induction phase of the treatment).  A secondary 
purpose was to examine a relationship between selected fitness parameters and fatigue 
assessed at the beginning and at the end of the exercise program. 
Hypotheses  
According to the purposes of the study it was hypothesized that: 
H1: There will be a significant difference in cardiorespiratory endurance between the 
beginning and the completion of the exercise program.   
H2: There will be a significant difference in overall muscular endurance between the 
beginning and the completion of the exercise program.  
H3: There will be a significant difference in overall fatigue levels between the beginning 
and the completion of the exercise program. 
H4: There will be a significant inverse relationship between changes in cardiorespiratory 
endurance and fatigue levels assessed prior to and at the end of the study. 
H5: There will be a significant inverse relationship between changes in overall muscular 
endurance and fatigue levels assessed prior to and at the end of the study.  
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Definition of Terms 
 
Acute Leukemia: A rapidly progressing blood cancer that starts in blood-forming tissue 
such as the bone marrow, and causes increased production of white blood cells that enter the 
blood stream and accumulate. 
Induction phase of treatment: Portion of the treatment when patients receive 
chemotherapy for a period of approximately 6 days following an in-hospital recovery period 
of approximately 3 weeks.  
Consolidation phase of treatment: After recovering at home for a period of two weeks 
post induction, patients return to the hospital to receive a second bout of chemotherapy 
(consolidation). Consolidation is the administration of chemotherapy every other day for a 
period of 6 days. After the 6th day, patients are usually released to return home for a three 
weeks recovery until returning to the hospital for further evaluation or another consolidation 
bout of chemotherapy. 
Blood cell count, also called complete blood count (CBC): A test to check the number of 
red blood cells, white blood cells, and platelets in a sample of blood.  
Platelet count: a test to check the number of platelets in a sample of blood. 
Overall muscular endurance: The summation of the results of the muscular endurance 
tests of the upper body (biceps curls) and lower body (squats) exercises.  
Cardiorespiratory endurance: Total time of cycling recorded at the end of the test. 
Heart Rate Reserve (HRR): Difference between patient’s maximum heart rate and resting 
heart rate. 
Fatigue: Usually is defined as a feeling of tiredness, weariness, or lack of energy.  
However, fatigue in cancer patients can be described as a complex phenomenon: as a lack of 
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concentration and a loss of memory (mental fatigue); an inability to begin task or a tendency 
to avoid social contacts and activities (volitional fatigue); tiredness and easy exhaustion from 
activities requiring physical effort (physical fatigue) (Dimeo, 2001).  
Assumptions  
• All patients enrolled in the study were able to complete the exercise protocol 3 to 4 
times per week during the entire study. 
• The impact of different drugs used during the treatment resulted in similar side effects 
experienced by the patients including fatigue and depression. 
• The patients only exercised during the scheduled exercise sessions followed the 
proposed exercise protocol. 
• Subjects honestly and accurately answered the Revised Piper Fatigue Scale. 
Delimitations     
• Subjects were recruited from the “Leukemia” unit of Oncology/Hematology division 
at the UNC-Hospitals. 
• Subjects participated in two exercise sessions per day, three days per week, with a 
minimal rest period between exercise sessions of 24 hours, for a total of 
approximately six weeks. 
• The exercise group exercised at intensities no higher than 60% of a predicted 
maximal capacity (60% of HRR or RPE of 4 on the CR10 Modified Borg Scale). 
 Limitations 
• This study was not a randomized controlled trial (Post-test design study). 
• The small sample size (n = 10) significantly decreases the power of the statistical 
analyses.  
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• The patients of a large age range (18-55 years old) may vary in physiological 
responses to exercise program.  
• Infections contracted by some of the patients during the study interrupted the exercise 
training protocol for more than two days. 
• Low blood cell count during the study (particularly platelet count) impeded some 
patients to exercise following the proposed scheduled exercise protocol. 
 
Significance of the Study 
The benefits of exercise for the cancer population have been reported in the literature to 
be a promising complementary therapy in combating side effects usually developed during 
cancer treatment (Adamsen et al., 2003; Courneya et al., 2003; Dimeo, 2001; Kolden et al., 
2002; Lucia et al., 2005; Winningham et al., 1989).  To our knowledge, this is the first study 
to explore the effects of exercise in the adult acute leukemia population during the induction 
phase of treatment.  Since leukemia patients are usually restricted to a hospital room for a 
period of approximately 4 weeks, during the induction phase of treatment, the association 
between decrease in physical activity levels and side effects commonly developed during 
treatment may exacerbate the decline in overall health usually observed in this population 
while undergoing treatment.  Furthermore, the physical health and the impact of the 
deconditioning process that is believed to occur due to diminished physical activity level, 
change in nutrition, and side effects developed during treatment can be devastating and 
interfering with desired treatment outcomes.  Therefore, present study was an attempt to 
examine the possible benefits of exercise in acute leukemia patients and to serve as a starting 
point for future research on acute leukemia population. 
  
 
CHAPTER II  
LITERATURE REVIEW 
 
Detrimental Side Effects of Cancer-Related Treatment 
 
Standard medical treatments have been proven to be safe and effective in fighting most 
types of cancer (Leukemia and Lymphoma Society, 2006).  Although standard treatments 
improve survival for individuals with all types of cancer including leukemia, treatment-
related side effects are commonly reported to have negative effect on recovery, physiological 
and psychological health of cancer patients (Servaes et al., 2002).  The most prevalent side 
effect experienced by cancer patients is fatigue.  According to several studies, fatigue affects 
from 48% to 96% of cancer population (Dimeo, 2001; Servaes et al., 2002; Winningham, 
2001).  Moreover, about 48-75 % of cancer patients undergoing treatment experience fatigue 
that is moderate to severe (Servaes et al., 2002).  This treatment-related fatigue can persist for 
years after cessation of treatment imposing limitations on normal daily activities.  
Other side effects, such as psychological distress and depression, are reported by 25% of 
cancer population (American Cancer Society, 2006) with depression often related to fatigue 
(Dimeo et al., 2004).  In order to reduce fatigue in patients undergoing treatment, they are 
often advised to rest and avoid physical exertion.  As a result, physical inactivity induces 
muscle wasting and diminished functional capacity.  Several studies report skeletal muscle 
wasting and cachexia as common treatment-related side effects that lead to loss of whole 
body strength (Al-Majid and McCarthy, 2001; Hemming and Maher, 2005).  Decrease in 
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cardiopulmonary efficiency and range of motion experienced by cancer patients leads to 
decrease in overall physical functioning  (Courneya et al., 2003).  Overall de-conditioning 
induced by decrease in body strength and functional capacity leads to easy fatigability and, 
paradoxically, to a further increase in fatigue (Dimeo et al., 1999).  All these side effects 
impose limitations on normal daily activities and in combination may undermine quality of 
life.  Several studies done on patients of various cancers reported diminished quality of life as 
a common effect of cancer and cancer-related treatment (Courneya et al., 2000; Schwartz, 
1999).  These physiological and psychological side effects not only impact overall treatment 
outcome and recovery process but may also persist for years after completion of the 
treatment potentially leading to premature mortality.  Therefore, there is a great need in 
understanding the preventive methods and complimentary therapies in managing cancer and 
cancer treatment-related side effects. 
 
Exercise as a Complementary Therapy in Managing Cancer and Cancer Treatment-
Related Side Effects 
Exercise therapy has been shown by many studies to have a positive effect on the 
recovery and normal functioning during and after the cancer-related treatment (Battaglini et 
al., 2006; Galvao and Newton, 2005).  In a recent review, Galvão and Newton (2005) 
summarizes twenty-six exercise intervention studies in various cancer populations.  The 
majority of the studies were conducted on breast or prostate cancer patients, and only very 
few were conducted on hematological diseases including leukemia (three studies), on 
stomach (one study) and on colorectal cancer (one study). The results of the majority of these 
studies demonstrate physiological and psychological benefits of regular exercise and suggest 
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that exercise therapy should be considered as an alternative treatment strategy to cope with 
cancer treatment-related side effects.  
Several studies on exercise intervention during or after the treatment used cardiovascular 
training and reported no detrimental effects in cancer patients of any age (Burnham and 
Wilcox, 2002; Shore and Shepard, 1999;  Marchese et al., 2004).  For example, Burnham and 
Wilcox (2002) showed that a low-to-moderate intensity aerobic exercise could be both safe 
and effective in breast or colon cancer survivors 40-65 years old.  Shore and Shepard (1999) 
and Marchese et al. (2004) also found that exercise was safe and beneficial for children of 4-
15 years old with acute leukemia. 
Aerobic exercise intervention has been shown to improve or at least maintain 
cardiovascular capacity (Dimeo et al. 1998) and lean body mass (Winningham et al., 1989).  
The latter study reported the effect of a 10- to 12-week aerobic exercise program on body 
composition of 24 breast cancer patients undergoing chemotherapy.  Twelve patients were 
randomly assigned to the exercise group, and twelve to the control group.  Patients in the 
control group received no exercise treatment but were asked to continue with their daily 
activities.  Exercise group participated in the individualized Winningham Aerobic Interval 
Training (WAIT) program three times per week for 20-30 minutes with intensities set at 
60%-85% of maximal heart rate.   All subjects were asked to maintain their eating patterns 
throughout their participation.  Upon completion of the WAIT program, the exercise group 
showed an increase in lean body mass and a decrease in percent body fat relative to the 
control group.  This suggests that exercise had a moderating effect on gain in body fat and 
loss of lean muscle tissue during the cancer treatment. 
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In the study by Dimeo et al. (1998) five patients with various cancer types participated in 
a 6-week aerobic training program. The program consisted of daily walking on a treadmill 
with intensity corresponding to lactate concentration of 3.0 ± 0.5 mmol/L. This lactate 
concentration was equivalent to the heart rate of 80 ± 5% of the maximum reached during the 
stress test.  The results of the training program demonstrated a significant improvement in 
maximal physical performance, measured as maximal walking speed and distance covered, 
as well as a reduction in heart rate and lactate concentration.  At the same time, all patients 
experienced reduction in fatigue and could perform their normal daily activities without 
limitations.  These results suggest that an aerobic exercise program of precisely defined 
intensity, frequency and duration can be prescribed as a therapy for fatigue in cancer patients.   
In their later study Dimeo et al. (1999) used control-group design to examine the effect of 
physical activity on fatigue and psychological status of cancer patients aged 18-60 years 
undergoing chemotherapy.  A group of twenty-seven patients with various cancers completed 
an exercise program consisting of daily biking on supine cycle ergometer for 30 minutes 
according to the interval-training pattern: each 1 minute of biking (with intensity of at least 
50% of heart rate reserve) was followed by 1-minute pause.  Thirty-two patients in control 
group did not exercise.  The duration of the exercise program was not specified but was 
described as supervised training carried out during hospitalization period.  By the time of 
hospital discharge, patients in the control group showed significant increase in fatigue and 
reduction in vigor while no changes were observed in the exercise group.  Furthermore, 
training group showed a significant decrease in psychological distress compared to control 
group.  
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 The results of several other studies (Burnham and Wilcox, 2002; Courneya et al., 2003; 
Schwartz et al. 1999) are also consistent with findings reported by Dimeo et al. (1998) and 
Dimeo et al. (1999) that aerobic exercise program can improve physical performance and 
decrease treatment-related fatigue.  Schwartz et al. (1999) showed that home-based aerobic 
exercise program of low-to-moderate intensity was feasible for women with breast cancer 
receiving chemotherapy.  Twenty-seven women, all over 18 years old, completed an 
unsupervised 8-week exercise program consisting of 15-30 minutes of unspecified self-paced 
aerobic exercises performed 3-4 times a week.  Patients were asked to exercise at intensity 
that would not provoke or intensify their symptoms.  Women who adopted the exercise 
program (60%) showed significant improvements in functional ability and quality of life.  
However, fatigue levels increased but this increase was related to the third dose of 
chemotherapy.  These results suggest that maximum effect of exercise on quality of life may 
be mediated by treatment-related fatigue. 
More recently, Burnham and Wilcox (2002) and Courneya et al. (2003) used control-
group design to examine the effect of aerobic exercise on both physiological and 
psychological functions in cancer patients.  Eighteen survivors of breast or colon cancer aged 
40-65 years, rehabilitating from cancer treatment (at least two month post treatment) 
participated in the study by Burnham and Wilcox (2002).  Subject were matched by relative 
aerobic capacity and quality of life and then randomly assigned to either a control group with 
no exercise (n = 7), a low-intensity (n = 7) exercise group or a moderate-intensity (n = 7) 
exercise group.  The results showed no difference between the two exercise groups. When 
both exercise groups were combined, the results showed that 10 weeks of low-to-moderate 
intensity (25-50% heart rate reserve) aerobic exercise program significantly improved 
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aerobic capacity, body composition, lower body flexibility, and quality of life compared to 
control group.  Moreover, fatigue and anxiety significantly decreased in the exercise groups 
but not in the control group.  
Courneya et al. (2003) had fifty-two postmenopausal breast cancer survivors (aged 50-69 
years) randomly assigned to an exercise (n = 25) or a control (n = 28) group.  The exercise 
group completed a 15-week supervised exercise program that consisted of biking on 
recumbent or upright cycle ergometer three times per week for 15 minutes during the first 
three weeks, gradually increasing to 35 minutes during weeks 13 through 15.  The control 
group did not train.  The exercise group showed significant improvements in peak oxygen 
consumption and overall quality of life when compared to the control group.  Moreover, 
results of correlation analysis indicated that the increase in peak oxygen consumption was 
correlated with the increase in quality of life (r = 0.45; p< 0.01) again suggesting beneficial 
effect of exercise on quality of life. 
However, study by Battaglini et al. (2004) found no significant relationship between 
reduction in fatigue and improvement in physical fitness (r = 0.32, p = 0.94).  Twenty-seven 
cancer patients (24-78 years old) undergoing treatment participated in a supervised exercise 
program two times per week for 24 weeks.  In this study the exercise program combined 
aerobic exercise, resistance training, and stretching exercises in a single exercise session.  An 
exercise session consisted of 5-10 minutes of stretching, 10-20 minutes of aerobic exercise 
using treadmill or cycle ergometer with intensity set at 50-55% of maximal cardiac 
frequency, and resistance exercises performed at 50% of a maximal repetition (1RM) for all 
major muscle groups.  Responses to the exercise program showed improvements in 
cardiovascular capacity (treadmill time) and muscular strength, and decreases in body fat and 
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overall fatigue score.  Statistical significance of the improvements was not reported.  
Although the relationship between reduction in fatigue and improvement in physical fitness 
was not significant, it was linear and positive suggesting a positive trend. 
 In another study conducted by Dimeo et al. (1997), the relationship between physical 
performance and fatigue was examined.  Maximal physical performance was assessed in 78 
patients with different cancers who performed treadmill test until voluntary exhaustion.  
Heart rate was recorded at the end of the test and VO2max was estimated for each patient. 
Patients’ psychological state was assessed by completing two questionnaires, the short 
version of the Profile of Mood Status (POMS) and the Symptom Check List (SCL-90-R).  
The results showed a strong correlation between intensity of fatigue and several indicators of 
psychological distress such as depression (r = 0.68) and anxiety (r = 0.63; p < 0.001 for 
both), while only a weak association between fatigue and physical performance (VO2max) 
was observed (r = -0.30; P < 0.01).  Furthermore, patients with higher levels of physical 
performance had significantly lower scores for depression {p = 0.005) and anxiety (p = 0.08) 
than patients whose physical performance was lower. 
 Similar to Battaglini et al. study, other studies used resistance training alone or in 
combination with cardio and flexibility exercises in order to explore the effects of different 
types of exercise on side effects of cancer treatment (Kolden et al., 2002; Segal et al., 2003).  
Segal et al. (2003) conducted a 12-week whole body resistance training program in patients 
with prostate cancer undergoing treatment.  Hundred and fifty-five males participated in the 
program consisted of two sets of 8-12 repetitions at 60-70% of 1 RM for all major muscle 
groups performed three times a week.  Results showed significant improvements in both 
upper (42%) and lower (36%) body strength, decrease in fatigue, and improvement of quality 
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of life with no change in body composition.  These outcomes suggest that resistance training 
could be beneficial in attenuation of treatment-related muscle wasting and fatigue.   
Kolden et al. (2002) performed a pilot study with exercise intervention that included a 
combination of cardiovascular, resistance and flexibility training.   Forty women over the age 
of 45, undergoing adjuvant therapies for breast cancer, participated in a supervised structured 
group exercise training (GET) three times per week for 16 weeks.  One-hour sessions were 
administered by two exercise physiologists and included 10-15 minutes warm-up, 20 minutes 
of different aerobic activities, 20 minutes of resistance training and a cool-down with 
emphasis on stretching.  Initial intensity levels were prescribed on the individual basis at 40–
60% of estimated maximal aerobic capacity that increased to 70% over the 16-week period.  
The results demonstrated that GET was feasible, safe, and well tolerated.  Furthermore, 
significant improvements were observed in whole body strength (estimated sub-maximum 
leg press and bench press), cardiovascular capacity (estimated VO2max) and flexibility (sit-
and-reach test).  Other important benefits of GET included a significant decrease in 
depression and improvement in the overall quality of life. 
 
Exercise Therapy and Acute Leukemia  
Side effects of traditional treatments for acute leukemia are reported to be similar to other 
cancers (Leukemia and Lymphoma Society, 2006).  Therefore, this study focuses on 
examining the effect of exercise on some of the major side effects such as increase in overall 
fatigue, and decrease in cardiovascular and muscular capacities. 
Review of existing literature on exercise and its effect on side effects of leukemia 
treatment showed that most of the research is focused on child leukemia as opposed to 
studies on adult.  One of the child leukemia studies (Marchese et al., 2004) was done on 
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twenty-eight children aged 4-15 years old with acute lymphoblastic leukemia (ALL) 
receiving maintenance chemotherapy.  A 4-month home-based exercise program consisting 
of ankle dorsiflexion stretching, lower extremity strengthening and aerobic exercise resulted 
in improved muscle function, stamina and overall quality of life.  Another study by Shore 
and Shephard (1999) demonstrated positive responses to a 12-week extra-hospital aerobic 
exercise program in six children aged 13-14 years, successfully treated for ALL and other 
types of neoplasm.  Results revealed significant improvements in maximal oxygen uptake, 
body composition, and anxiety scores upon completion of aerobic training at 70-85% of 
maximal heart rate three times a week for 12 weeks.  
The most recent study by San Juan et al. (2007) also showed that young children in the 
maintenance phase of treatment against ALL could safely perform both aerobic and 
resistance training.  Seven children 4-7 years of age completed 16-week intrahospital 
individually supervised exercise program consisting of resistance (11 exercises for major 
muscle groups) and aerobic training (30 min at about 70% maximum heart rate) performed 
three times a week.  The results revealed significant increase in peak oxygen uptake 
(VO2peak), ventilatory threshold (VT), upper- and lower-body muscular strength, and 
functional mobility.  Moreover, after a 20-week detraining period muscular strength was well 
maintained (significantly greater than before training and not significantly lower than after 
training). However, VO2peak, VT, and functional mobility were only partially retained (not 
significantly different from before and after training).  No significant improvements in 
quality of life or ankle range of motion were found. 
In contrast to many child acute leukemia studies, there are very few studies focused on 
adults with acute leukemia, especially performed during the treatment.  Moreover, these 
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existing studies use different types of exercise intervention and report contradictory results.  
Two studies showed that two different exercise intervention programs had no significant 
effect on either muscular or cardiovascular fitness but showed trends towards preserving 
them (Cunningham et al., 1986; Dimeo et al., 2003).  Cunningham et al. (1986) found no 
effect of 5-weeks resistance training program (3-5 times a week at unspecified intensity) on 
skinfold measures, arm circumference and nitrogen balance in 30 leukemia patients 14-44 
years old.  Patients were studied during recovery from bone marrow transplantation.  The 
only significant finding observed was decreased level of creatinine excretion, which 
indicated muscle protein-sparing effect of exercise and diminishing muscle protein loss 
during the treatment.  
The results of the second study by Dimeo et al. (2003) are in agreement with findings by 
Cunningham et al. (1986) showing no change in physical performance (walking speed) in 
response to a 2-week in-hospital aerobic exercise program.  Sixty-six patients (20-73 years 
old) with hematological malignancies (including leukemia) started the exercise program 
while undergoing chemotherapy.  All patients walked on a treadmill every day for about 33 
minutes using an interval-training pattern: after 3-minute warm-up, the patients walked 3 
minutes at a speed corresponding to 70% of their maximum heart rate; followed by 3-minute 
walk at half speed to recover.  Although walking speed did not change upon completion of 
the study, Dimeo et al. concluded that daily aerobic exercise mitigated treatment-related loss 
of physical performance and showed the trend towards preserving it. 
However, a third study, by Adamsen et al. (2006), showed that multidimensional exercise 
program significantly improved whole body strength and cardiovascular capacity in various 
cancer patients undergoing chemotherapy.  Eighty-two cancer patients (16 with 
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hematological malignancies) aged 18-65 years participated in a 6-week high-intensity 
supervised exercise program for 9 hours a week. The program consisted of cycling at 60-
100% of maximal heart rate, resistance training at 85-95% of 1RM (5-8 repetitions for major 
muscle groups), and massage and relaxation exercises.  The program resulted in a significant 
increase in muscular strength (32.5%) and cardiovascular capacity (16% increase in VO2max).  
The patients also reported significant reduction in pain and fatigue.  Although some measures 
of quality of life and well-being improved, no significant changes were found in overall 
quality of life. 
As a summary, results of all these studies suggest that exercise program is feasible, safe, 
well-tolerated, and beneficial for patients with any type of cancer, including leukemia, during 
and after the cancer-related treatment. 
 
 
 
 
 
CHAPTER III 
 
METHODOLOGY 
 
This study was designed to examine the effects of an individualized exercise prescription 
on selected fitness parameters and fatigue in acute leukemia patients undergoing 
chemotherapy (Induction phase of the treatment).  A secondary purpose was to examine if a 
relationship exists between the selected fitness parameters and fatigue assessed during the 
study.  This study is retrospective in nature and used archived data from “The EQUAL 
Project” study (Exercise and Quality of Life in Leukemia/Lymphoma Patients) conducted at 
UNC Chapel Hill. 
Subjects 
Patients were volunteers recruited from the University of North Carolina Hospitals 
(UNC-CH Hospitals), division of Oncology/Hematology.  A group of 10 patients with acute 
leukemia, males and females, were recruited for this study.  The inclusion criteria were as 
follow:  
• Newly diagnosed with acute leukemia or newly relapsed and receiving re-
induction therapy for acute leukemia; 
• An expected hospital stay of 3-4 weeks or longer; 
• Participation in the study had to be approved by the physician directly responsible 
for the patient’s care while at UNC-CH Hospitals; 
• Designated for chemotherapy treatment; 
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• Ages ranging from 18 to 55 years at the time of the study. 
Participation in this study involved the same risks as any exercise regimen.  Given the 
potential risks involved, patients were screened for exclusion based upon the following 
exclusion criteria: 
• Cardiovascular disease (unless the disease would not compromise the patient’s 
ability to participate in the exercise rehabilitation program); 
• Acute or chronic respiratory disease that would compromise the patient’s ability 
to participate in the exercise rehabilitation program; 
• Acute or chronic bone, joint, or muscular abnormalities that would compromise 
the patient’s ability to participate in the exercise rehabilitation program; 
• Immune deficiency that would compromise the patient’s ability to participate in 
the exercise rehabilitation program. 
Each patient was introduced to the study protocol and informed about the risks involved 
with exercise regimen.  Prior to participating in the study each patient signed a Consent form, 
approved by the University of North Carolina at Chapel Hill Biomedical Institutional Review 
Board.  
General Procedures 
Recruitment of Subjects 
Patients were introduced to the research study by oncology physicians from the UNC-CH 
Hospitals during the diagnostic meeting.  Oncology physicians were provided with an 
advertisement flier for the study containing the purpose, a brief explanation of study 
protocols, and research team members’ information (Appendix I).  When a patient expressed 
interest in participating, the physician passed the patient’s information to the nurse 
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coordinator of the oncology unity and member of the research team.  The nurse coordinator 
then contacted the principal investigator or the oncology research nurse member of the 
research team and a visit was scheduled to the patient’s room.  The principal investigator or 
the oncology research nurse then visited the patient at the patient’s hospital room and 
discussed more information about criteria for participation and a more detail explanation of 
the study protocols was given at that time.  After all questions were answered regarding the 
study protocol and the patient agreed to participate in the study, subjects were then asked to 
sign an informed consent form and the HIPAA authorization form for use and disclosure of 
health information for research purposes.  Then an initial assessment meeting was scheduled. 
During this visit, patients also received pre-assessment guidelines (Appendix II).  The initial 
assessment was scheduled to take place within three days post-diagnosis/beginning of the 
induction (phase 1) treatment.   
Each patient recruited for the study participated in an approximately 6-week exercise 
rehabilitation program.  Following the initial assessment, all subjects enrolled in the study 
participated in an individualized prescriptive exercise intervention 3-4 times per week for a 
period of approximately 3-4 weeks or longer.  After patients were released from hospital for 
2 weeks of recovery they were asked to continue unsupervised exercise prescription.  The 
final assessment was administered upon patient’s coming back to the hospital for another 
bout of treatment (consolidation phase).  Table 1 below represents summary of events 
according to the study protocol timeline. 
Assessment Protocol 
All assessments and the exercise program were administered in the patient’s room in the 
hospital by the investigator or a Research team member.  Prior to the administration of the 
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initial assessments, subjects received further information about the study, in-depth 
explanation of all assessment protocols, and explanations regarding the exercise regiment.  A 
physician from the research team reviewed the patient’s medical file and determined if the 
patient was able to participate in physical activity.  The physician also made 
recommendations on physical limitations that were to be taken into consideration during the 
assessment and the administration of exercise intervention.  
Table 1. Timeline of study protocol events. 
 
Week Day Event 
1 1 
 
 
 
 
 
1 or 2 
 
 
 
 
2 or 3 
 
 
4 
Introduction to the study by physician  
 
Physician referral to nurse coordinator 
 
Nurse coordinator contacts research team 
member 
 
Research team member visit to patient’s room 
(information about the study, secured informed 
consent, arrange initial assessments meeting, 
and information on pre-assessment guidelines) 
 
Administration of initial fitness and fatigue 
assessments 
 
Exercise intervention began 
 
 
2, 3, 4, and or 5  
 
 
3-4 times per week 
 
Administration of intervention 
 
5,6 or 6,7 -  
2 weeks of home 
recovery 
 
 
3-4 times per week 
 
Home based aerobic exercise 
Week 7 or 8, 
following home 
recovery 
Immediately after 
re-admission to 
hospital (prior to 
consolidation 
treatment) 
Administration of final fitness and fatigue 
assessments 
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The assessments included: 
1. The Revised Piper Fatigue Scale. 
2. Resting heart rate (RHR), blood pressure (BP), and pulse oximetry for the 
determination of hemoglobin saturation. 
3. Body weight, height, body circumferences (anthropometry), and body composition. 
4. Cardiorespiratory endurance test. 
5. Dynamic muscular endurance tests. 
For the assessment of fatigue, The Revised Piper Fatigue Scale questionnaire was used 
(Appendix III). The Revised Piper Fatigue Scale was administered by an oncology research 
nurse clinician prior to the administration of the fitness assessments.  
Two fitness assessments were administered to all participants. The fitness assessments 
included the assessment of resting vitals (blood pressure, heart rate, and hemoglobin 
saturation), anthropometric measures (body weight, height, and body circumferences), 
cardiorespiratory endurance, and a dynamic muscular endurance test. All fitness assessments 
were performed by the primary investigator.  
The assessment of resting vitals was performed immediately after the administration of 
the questionnaires. Heart rate was assessed using a heart rate monitor, blood pressure via 
mercury sphygmomanometer, and hemoglobin saturation via a finger pulse oximeter. Weight 
and height were assessed using a balance beam physician scale equipped with height rod. 
Body circumferences were assessed following the standardized sites for circumference 
measures, as recommended by the American College of Sports Medicine (ACSM, 2006). The 
sites that were used for the assessment of body circumferences included shoulder, chest, 
arms, waist, gluteus, thighs, and calves. 
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The cardiorespiratory assessment was performed on a recumbent cycle ergometer or 
treadmill. The subject was asked to cycle or walk at a target submaximal intensity of 60 % of 
their percentage of heart rate range (%HRR determined by using the Karvonen method) until 
a RPE (Rate of Perceived Exertion) of 7 was reached on the modified Borg Scale or when the 
subject requested termination. The Borg modified RPE scale is a scale ranging from 0 to 11 
where 0 means no exertion at all and 11 equals to an exertion of absolute maximum 
(Appendix IV). The total time of cycling or walking was recorded immediately after the test 
was completed.  The administration of the cycle or the treadmill test was determined 
according to the patient’s physical limitations to perform either on a cycle ergometer or a 
treadmill.  Patients who were not able to perform the cardiorespiratory test on the bike 
performed the treadmill test and patients unable to perform on the treadmill were tested using 
a cycle ergometer. 
The assessment of dynamic muscular endurance was the last of the fitness assessments 
and included two tests. The first test was a leg squat exercise using the fit ball (large, ~ 65cm 
in diameter, soft plastic/rubber ball) performed with no external load besides the patient’s 
own body weight. To perform squat exercise subject was required, with the assistance of the 
exercise specialist team member, to stand with back towards the wall, feet shoulder width 
apart, and the fit ball placed between wall and subject’s back.  The subject was asked to squat 
to a 75 degree knee angle with a moderate speed, pressing back against the ball at all times.  
This exercise was repeated until the subject achieved an RPE of 7 or required to stop.  The 
second muscular endurance test was the bicep curl exercise. The bicep curl test was 
performed following a protocol developed at the Rocky Mountain Cancer Rehabilitation 
Institute (RMCRI), Greeley, Colorado (Appendix V). The protocol involved the 
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administration of the biceps curls done with dumbbells.  Subject was asked to perform as 
many repetitions as possible during an alternated biceps curl exercise using a percentage of 
their body weight as resistance. The percentage of body weight to be lifted was calculated 
according to the protocol developed at the RMCRI.  The test was terminated when the 
subject reported an RPE of 7 or required to stop.   
Exercise Protocol 
The exercise program began approximately 24 hours after the completion of initial 
assessments.  Each patient followed an individualized prescriptive exercise program 3-4 
times per week with at least 36 hours of rest in between the sessions.  The duration of each 
exercise session depended on patient’s physical state on the day of exercise.  Each exercise 
session were divided into two bouts. One bout was administered in the morning and the 
second one late in the afternoon. By exercising in two different periods of the day, patients 
did not have to exercise for longer than 30 minutes each bout. There was a period of rest of at 
least 36 hours between each exercise sessions (i.e. if a patient exercised on Tuesday, the next 
exercise session was administered on Thursday).  
All patients exercised in his/her room in the hospital with all necessary equipment 
provided.  Each exercise session included: 3-5 minutes of light stretching, 5-10 minutes of 
cycling on the recumbent cycle ergometer or walk on the treadmill, 5-15 minutes of 
resistance training (with dumbbells, resistance bands and exercise ball), and 5-10 minutes of 
core exercises.  All exercises were performed at submaximal intensities determined using 
Heart Rate Reserve (HHR) for cardiorespiratory exercise and RPE for the resistance portion 
of the exercise bout.  Intensity was constantly monitored never exceeded 5 on the CR10 
modified Borg scale for any exercise performed during the session. Every exercise session 
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followed the same structure; however, the morning exercise period focused on exercises for 
the upper body while the afternoon session focused on exercises for the lower body during 
the resistance portion of the exercise training. The exercises that were used to target the 
upper portion of the patient’s body (upper body exercises) include lateral, frontal, or military 
press for shoulders, chest press with dumbbells or rubber bands for chest, low rows with 
rubber bands for back, and arm curls and arm extension with dumbbells or rubber bands for 
arms. The exercises that were used for the lower body workouts will include leg extension 
and leg curls with rubber bands, squats using the fit ball, and calf raises. Abdominal exercises 
were administered during every exercise bout. The exercises that targeted the abdominal 
region included regular crunches (curl-ups), and oblique abdominals performed on a chair.  
The amount of time for each component of the exercise period was adjusted according to 
the physical state of the patient prior and during each session. If a patient reported to be 
extremely tired prior or during an exercise session, the duration of the session was 
significantly reduced, while during days when patients felt better, the length of each exercise 
training session were lengthened but never longer than 30 minutes.  
The exercise intervention was administered by the primary investigator or a research 
team member at the hospital for approximately 3-4 weeks or until the patient was released 
from the treatment to recover at home.  During the two weeks of home recovery, induction 
phase of the treatment, patients were asked to continue exercising following a prescribed 
program composed of aerobic activities (primarily regular walks).  After coming back to the 
hospital for consolidation treatment, the patients underwent the same battery of assessments 
administered at the beginning of the study protocol.  
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Instrumentation 
Selected fitness parameters (cardiorespiratory endurance and muscular endurance) of 
each subject were assessed two times in the study. The first fitness assessment was 
administered within three days of diagnosis and the second one at the end of the study, after 
two weeks of the in-home self-administered exercise program.  Each patient wore an F1 
Polar heart rate monitor (Lake Success, NY) to assess both resting heart rate and heart rate 
during the assessments and exercise sessions. Intensity of cardiovascular exercise was 
monitored using an A3 Polar heart rate monitor (Lake Success, NY) and adjusted based on 
each subject’s self-reported feelings of exertion (Borg CR 10 Rate of Perceived Exertion 
(RPE) Scale).  Height and body weight were assessed using a Detecto Model 437 Physician 
Beam Scale (Webb City, MO).  A body fat analysis was performed with an Omron HBF-306 
Bio-Impedance Body Logic analyzer (Vernon Hills, IL) and Lange C-130 Beta Technology 
calipers (Cambridge, MD). Circumference measurements followed standardized sites for 
circumference measurements (ACSM’s Guidelines, 2006) using anthropometric measuring 
tape by Creative Health Products (Ann Arbor, MI).  An ADC 922 Series aneroid 
sphygmomanometer (Hauppauge, NY) and a Littmann Stethoscope (St. Paul, MN) were used 
to assess blood pressure. Cardiovascular endurance assessments were performed on a 
Recumbent bike model cateye EC 3500 (Dallas,TX) or Treadmill (Pro-Form model 350, 
Logan, UT) . Muscular endurance/strength exercises (lateral and frontal raises, military press, 
chest press, low rows, biceps curls, triceps extensions, leg extensions, squats, leg curls, and 
calf raises) were performed using deluxe vinyl dumbbells, ranging from 2 to 15 pounds, from 
Power Systems Sports (Knoxville, TN) and/or rubber tubing (Dyna Bands), with strengths 
varying from light, to medium, to heavy (Power Systems Sports; Knoxville, TN).   
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Statistical Analyses 
All data were gathered and entered into an electronic database for analysis.  Then all data 
were analyzed on SPSS version 14.0 for Windows, a statistical software program. 
Descriptive statistics are presented in the form of means and standard deviations. Each 
hypothesis was analyzed as follows:  
Hypothesis 1 stated that there will be a significant difference in cardiorespiratory 
endurance between the beginning and the completion of the exercise program. It was tested 
using a paired samples t-test. The dependent variable, cardiorespiratory endurance was 
assessed within three days post-diagnosis/beginning of the induction treatment (initial 
assessments) and at the end of the study (final assessment, prior to consolidation treatment). 
The variable used to measure cardiorespiratory endurance was total time of cycling until RPE 
of 7 was reached or until the subject requested termination, as explained in detail above. 
Hypothesis 2 stated that there will be a significant difference in overall muscular 
endurance between the beginning and the completion of the exercise program. It was tested 
using a paired samples t-test.  In this case, the dependent variable used for analysis was the 
summation of the results  (total number of repetitions) of the muscular endurance tests of the 
upper body (biceps curls) and lower body (squats) exercises, assessed at the beginning of the 
induction treatment (initial assessment) and at the end of the study (final assessment).  
Hypothesis 3 stated that there will be a significant difference in overall fatigue between 
the beginning and the completion of the exercise program.  It was tested using a paired 
samples t-test.  The dependent variable, overall fatigue level was assessed within three days 
post-diagnosis/beginning of the induction treatment (initial assessments) and at the end of the 
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study (final assessment).  Initial and final total scores of the Revised Piper Fatigue Scale 
were recorded and used for the analysis.  
Hypothesis 4 stated that there will be a significant inverse relationship between changes 
in cardiorespiratory endurance and fatigue levels assessed prior to and at the end of the study.  
It was tested using regression analysis.  The variables included in the regression model were 
the change score for the cardiorespiratory endurance and change score for the fatigue, where: 
• Independent variable, change score for cardiorespiratory endurance (∆CE) was 
calculated as ∆CE = Total time of cycling (final assessment) – Total time of cycling 
(initial assessment). 
• Dependent variable, change score for fatigue level (∆F) was calculated as ∆F = Total 
score of fatigue (final assessment) – Total score of fatigue (initial assessment) 
Hypothesis 5 stated that there will be a significant inverse relationship between changes 
in overall muscular endurance and fatigue levels assessed prior to and at the end of the study. 
It was tested using regression analysis. The variables included in the regression model were 
the change score for the overall muscular endurance and the change score for the fatigue, 
where: 
• Independent variable, change score for muscular endurance (∆OME) was calculated as 
∆OME =  Total number of repetitions (final assessment) – Total number of repetitions 
(initial assessment) 
• Dependent variable, change score for fatigue level (∆F) was calculated as 
∆F = Total score of fatigue (final assessment) – Total score of fatigue (initial 
assessment)
 
  
 
CHAPTER IV 
RESULTS 
 
All data were gathered and entered into an electronic database for analysis.  All data were 
analyzed using SPSS version 14.0, a statistical software program for Windows.  A 
significance level of 0.05 was used for all statistical tests.  Hypotheses 1 –3 were analyzed 
using paired samples t-tests, while hypotheses 4 and 5 were analyzed using simple linear 
regression.  Descriptive statistics of all variables are presented in the form of means and 
standard deviations. 
Subjects 
Patients were volunteers recruited from the University of North Carolina Hospitals 
(UNC-CH Hospitals), division of Oncology/Hematology.  A group of 10 patients aged from 
18 to 55 diagnosed with acute leukemia were recruited for this study.  Two patients were 
later excluded from the study due to either severe health issues or moving to another hospital 
to complete treatment.  Only 8 patients, 6 males and 2 females aged from 24 to 48, completed 
the study protocol.  Their characteristics are summarized in Table 2 below. 
Table 2. Subjects’ characteristics.   
 
Age  
(years) 
Height 
 (cm) 
Body Weight  
(kg) 
Body 
Composition  
(% Body Fat) 
Mean SD Mean SD Mean SD Mean SD 
Acute leukemia 
patients  35.8 8.9 172.7 8.1 99.0 32.3 25.2 9.3 
  n = 8 
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Hypothesis 1 
Hypothesis 1 states that there will be a significant difference in cardiorespiratory 
endurance between the beginning (CREpre) and the completion (CREpost) of the exercise 
program.  It was tested using a paired samples t-test.  The variable used to measure 
cardiorespiratory endurance was total time of cycling in minutes until subject reached RPE of 
7 or requested termination.  The descriptive statistics of the analyses of Hypothesis 1 is 
presented in Table 3 below.  
Table 3. Descriptive statistics of cardiorespiratory endurance at the beginning and the 
completion of exercise program. 
 
Variable Mean SD 
CREpre (minutes) 8.94 8.88 
CREpost (minutes) 17.01 14.32 
n = 8 
 
A statistically significant difference was found in cardiorespiratory endurance at the 
completion of the exercise program when compared to baseline measures (p= 0.009).  Table 
4 below presents the results of the t-test used to analyze Hypothesis 1. 
Table 4. Difference in cardiorespiratory endurance at the beginning and the completion of 
exercise program (t-test). 
 
n = 8 
 
Hypothesis 2 
Hypothesis 2 states that there will be a significant difference in overall muscular 
endurance between the beginning and the completion of the exercise program.  It was also 
 
  
Paired Differences 
t 
  
df 
  
Sig. (2-tailed) 
  Mean Std. Deviation 
Std. Error 
Mean 
CREpost - CREpre 8.07 6.41 2.26 3.561 7 0.009 
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tested using a paired samples t-test.  In this case, the dependent variable used for analysis was 
the summation of results  (total number of repetitions) of the muscular endurance tests of the 
upper body (biceps curls) and lower body (squats) exercises, assessed at the beginning 
(OMEpre) and at the end of the study (OMEpost).  The descriptive statistics of the analysis 
of Hypotheses 2 are presented in Table 5.   
Table 5. Descriptive statistics of overall muscular endurance at the beginning and the 
completion of exercise intervention. 
 
Variable Mean SD 
OMEpre (repetitions) 57.50 21.35 
OMEpost (repetitions) 61.25 24.01 
 n = 8 
 
No statistically significant difference was found in overall muscular endurance at the 
completion of the exercise program when compared to baseline measures (p= 0.715).  Table 
6 below presents the results of the t-test used to analyze Hypothesis 2. 
Table 6. Difference in overall muscular endurance at the beginning and the completion of 
exercise program (t-test).  
 
 n = 8 
 
Hypothesis 3 
Hypothesis 3 states that there will be a significant difference in overall fatigue levels 
between the beginning and the completion of the exercise program.  It was tested using a 
paired samples t-test.  The dependent variable, overall fatigue level was measured using total 
scores on the Revised Piper Fatigue Scale, assessed at the beginning of the induction 
 
  
Paired Differences 
t 
  
df 
  
Sig. (2-tailed) 
  Mean 
Std.  
Deviation 
Std.  
Error Mean 
OMEpost -OMEpre 3.750 27.920 9.87 .380 7 0.715 
  33
treatment and at the end of the study.  The descriptive statistics of the analysis of Hypotheses 
3 are presented in Table 7 below.  
Table 7. Descriptive statistics of overall fatigue levels at the beginning and the completion of 
exercise intervention. 
 
Variable Mean SD 
Fatigue (pre) 4.60 1.73 
Fatigue (post) 1.80 1.67 
  n = 8 
 
A statistically significant difference was found in overall fatigue levels at the beginning 
and the completion of the exercise program (p= 0.009). Table 8 below presents the results of 
the t-test used to analyze Hypothesis 3. 
Table 8. Difference in overall muscular endurance at the beginning and the completion of 
exercise program (t-test). 
 
  n = 8 
 
Hypothesis 4 and 5 
Hypotheses 4 and 5 were analyzed using a simple linear regression model and included 
the following variables: the change score for the cardiorespiratory endurance (∆CRE), the 
change score for the overall muscular endurance (∆OME), and the change score for overall 
fatigue level (∆F). The descriptive statistics for these three variables for a simple linear 
regression analyses are presented below in Table 9. 
 
  
Paired Differences 
t 
  
df 
  
Sig. 
 (2-tailed) 
  Mean 
Std. 
Deviation 
Std.  
Error Mean 
Fatigue(post) –Fatigue(pre) -2.800 2.204 .779 -3.593 7 0.009 
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Table 9. Descriptive Statistics for Simple Regression Analysis. 
Variable Mean SD 
∆CRE 8.07 6.41 
∆OME 2.75 23.95 
∆F -2.80 2.20 
  n = 8 
 
Hypothesis 4 
Hypothesis 4 states that there will be a significant inverse relationship between changes 
in cardiorespiratory endurance and overall fatigue levels assessed prior to and at the end of 
the study.   The independent variable in the regression was the change score for the 
cardiorespiratory endurance (∆CRE), calculated as the difference in total time of cycling 
between the final and initial assessments (∆CRE = CREpost - CREpre).  The dependent 
variable was the change score for overall fatigue level (∆F), calculated as the difference in 
total score of fatigue between the final and initial assessments (∆F = Fatigue(post) – 
Fatigue(pre).  No statistically significant relationship was found between ∆CRE and ∆F in this 
test (r (7) = -0.26, p = 0.534).  The non-significant results of the regression analysis of 
Hypotheses 4 are presented in Table 10 below. 
Table 10. Relationship between changes in cardiorespiratory endurance and overall fatigue 
levels. 
 
 ∆F 
∆CRE 
R2 .068 
Slope -.089 
P value .534 
n = 8 
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Hypothesis 5 
Hypothesis 5 states that there will be a significant inverse relationship between changes 
in overall muscular endurance and overall fatigue levels assessed prior to and at the end of 
the study. The independent variable in the regression was the change score for the overall 
muscular endurance (∆OME), calculated as the difference in total number of repetitions 
between the final and initial assessments (∆OME = OMEpost – OMEpre).  The dependent 
variable was the change score for fatigue level (∆F), calculated as the difference in total score 
of fatigue between the final and initial assessments (∆F = Fatigue(post) – Fatigue(pre).  No 
statistically significant relationship was found between the ∆OME and ∆F in this test (r (7) = -
0.335, p = 0.417).  The non-significant results of the regression analysis of Hypotheses 5 are 
presented in Table 11 below.   
Table 11. Relationship between changes in overall muscular endurance and overall fatigue 
level. 
 
 ∆F 
∆OME 
R2 .112 
Slope -.026 
P value .417 
n = 8 
  
 
CHAPTER V  
DISCUSSION, CONCLUSION, AND RECOMMENDATIONS 
Introduction 
Although standard treatments improve survival for individuals with all types of cancer 
including leukemia, treatment-related side effects are commonly reported to have negative 
effect on recovery process, physiological and psychological health of cancer patients, and can 
potentially interfere with desired treatment outcomes (Servaes et al., 2002; Hemming and 
Maher, 2005).  These physiological and psychological changes may also persist for years 
after completion of the treatment and can lead to functional disability and premature 
mortality (Battaglini et al., 2006).  Therefore, there is a great need in understanding the 
preventive methods and complimentary therapies in managing cancer and cancer treatment-
related side effects. 
The benefits of exercise for the cancer population have been reported in the literature to 
be a promising complementary therapy in minimizing or even reverting both physiological 
and psychological side effects of cancer and cancer treatment (Adamsen et al., 2006; 
Courneya et al., 2003; Cunningham et al., 1986; Dimeo, 2001; Segal et al. 2003; Kolden et 
al., 2002).  However, the majority of these studies were conducted on breast and prostate 
cancer patients using different exercise protocols making it difficult to compare their results.  
Segal et al. (2003) and Cunningham et al. (1986) used resistance training only, Courneya et 
al. (2003) and Dimeo et al. (2001) conducted aerobic training program, while studies by 
Adamsen et al. (2006) and Kolden et al. (2002) used a combination of aerobic, resistance and 
  37
flexibility exercises.  Several studies used unsupervised exercise protocol; others performed 
supervised in-hospital training and used different modes and intensities of exercise.  
In the present study, a combination of aerobic, resistance, and flexibility exercises 
performed at low to moderate intensities were used as the exercise protocol.  Moreover, each 
exercise session was supervised and individually prescribed for each patient depending on 
his/her health status on the day of exercise.  
The current study was the first study to explore the effects of exercise on the adult acute 
leukemia population during the induction phase of treatment. Therefore, the primary purpose 
of this study was to examine the effects of an individualized exercise prescription on selected 
physical fitness parameters (cardiorespiratory and overall muscular endurance) and overall 
fatigue in acute leukemia patients undergoing chemotherapy.  A secondary purpose was to 
examine a relationship between selected fitness parameters and fatigue assessed at the 
beginning and at the end of the exercise program. 
 
Improvement in Cardiorespiratory Endurance 
According to Hypothesis 1, there would be a significant difference in cardiorespiratory 
endurance (CRE) between the beginning and the completion of the exercise program.  The 
results of the analyses showed a significant improvement in CRE measured as total cycling 
time (p= 0.009).  These results are consistent with the results of two other studies that 
performed similar exercise protocol including a combination of cardiovascular, resistance 
and flexibility training (Adamsen et al., 2006; Kolden et al., 2002).  Adamsen et al. (2006) 
showed that a 6-week high-intensity supervised exercise program improved cardiovascular 
capacity (VO2max) by 16% in various cancer patients including leukemia.  A pilot study 
performed by Kolden et al. (2002) with women undergoing adjuvant therapies for breast 
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cancer also reported significant improvement in cardiorespiratory fitness after completion of 
16-week structured supervised group exercise training.  
In contrast to the results of the current study, Dimeo et al. (2003) reported no change in 
CRE (walking speed) in response to an in-hospital aerobic exercise program administered to 
patients with various different types of blood cancer.  The intervention used in Dimeo et al. 
study lasted 2 weeks and included aerobic training only, compared to a 6-week combined 
training protocol of the current study.  Significant physiological adaptations to an exercise 
program usually occur within first 3-8 weeks (ACSM’s guidelines, 2006), therefore 2 weeks 
was probably not enough to elicit any significant change, especially in the cancer population.  
Although walking speed did not change in Dimeo et al. study, daily aerobic exercise reduced 
treatment-related loss of physical performance and showed the trend towards preserving it.  
This is a very important observation to note because once chemotherapy begins, patient’s 
blood cell count drops drastically, resulting in severely compromised immune and 
cardiovascular systems, increase in overall tiredness and fatigue, leading to decrease in 
physical activity, followed by overall deconditioning, and decline in overall patients’ health 
(Battaglini et al., 2006).   
The results of the current study showed that improvement in the CRE can be achieved in 
acute leukemia patients undergoing treatment.  The possible explanation could be that the 
intensity, frequency and duration of the exercise prescription adopted for each patient 
individually allowed for improvements in CRE.  The exercise sessions were conducted twice 
a day at light to moderate intensity just long enough to elicit RPE of 4 on the Borg Modified 
Scale, which seemed to be well tolerated by all patients. Therefore, the exercise protocol 
used in the current study seemed to be an appropriate protocol to use in acute leukemia 
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population.  In addition, the fact that benefits of the exercise were explained to each patient 
and every exercise session was supervised and encouraged, could have potentially given 
patients hope and psychological support while combating the disease.  These psychosocial 
factors may have contributed to motivation to perform exercise that was observed throughout 
the program.  
There have been many other studies involving the use of aerobic exercise in other types 
of cancer besides patients with blood cancers.  The majority of the studies have reported 
significant improvements in CRE (Burnham and Wilcox, 2002; Courneya et al., 2003; 
Marchese et al., 2004; Schwartz et al. 1999).  The current study suggests that similar positive 
response of CRE to aerobic exercise may also be attained in the acute leukemia population. 
 
Effect of Exercise on Overall Muscular Endurance  
According to Hypothesis 2, there would be a significant difference in overall muscular 
endurance (OME) between the beginning and the completion of the exercise program.  The 
results of the analyses showed no significant changes in OME (p = 0.715).  Cunningham et 
al. (1986) reported similar findings where 5-week resistance training program had no effect 
on arm circumference and skinfold measurements among 30 leukemia patients recovering 
from bone marrow transplantation.  It is important to note that no change in muscular fitness 
parameters found in both Cunningham et al. and this studies suggest that resistance training 
may be used to preserve muscle mass and to combat the muscle wasting effect, which is 
often observed in cancer patients undergoing chemotherapy (Al-Majid and McCarthy, 2001).  
Two other studies that used a similar multidimensional exercise program to the current 
study, found significant improvements in both upper and lower body strength of patients of 
various types of cancer (Adamsen et al., 2006; Kolden et al., 2002).  However, a higher 
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frequency of the exercise sessions in Adamsen et al. study (9 hours a week), much longer 
duration of the exercise intervention in Kolden et al. study (16 weeks), and differences in 
cancer populations, may all explain the difference in the results between these studies and the 
current one.  Moreover, different tests were used to assess upper and lower body strength.  
Also, multiple types of resistance exercises were performed in both of the abovementioned 
studies targeting all major muscles of the body.  This was different from the protocol used in 
the current study, which was limited to only a small number of exercises.  The OME measure 
in the current study only included two muscle groups (biceps and quadriceps), and may not 
have reflected well the patient’s actual overall muscular endurance.  
In addition, some patients in the current study were unable to perform upper body 
resistance training in the amount and frequency expected under the proposed exercise 
protocol, due to a port or IV inserted in either side of the chest or arms.  Therefore, some 
patients ended up decreasing upper body muscular endurance, which affected OME, since 
OME combined the results of the endurance tests administered for upper and lower body.  
This could have compromised the overall results of the analyses.   
Moreover, Kolden et al. (2002) created a protocol with intensity progression based on 
functional capacity and health status of the subjects.  No progression in the exercise intensity 
was attempted in the current study, as it was maintained at low levels to avoid possible 
injuries or complications, and varied significantly from day to day according to the physical 
state of each patient prior to each exercise session.   
There are several other possible explanations for the absence of significant changes in 
OME in the current study.  Individual differences in age, gender and fitness level resulted in 
a large variability of the sample, and may have compromised the significance of the results.  
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The psychological impact of the disease sometimes did not allow for consistency in the 
administration of the exercise protocol, imposing another challenge to the study.  For 
example, one of the patients was experiencing a high level of depression during the study and 
was not willing to exercise even after encouragement from physicians, nurses, and research 
team personnel.  His OME decreased by the end of the study creating an outlier and 
increasing the variability of the responses.   
Furthermore, some patients experienced nausea during the treatment and could not 
maintain an adequate diet.  All patients were consuming hospital food during 4 weeks of the 
induction phase of treatment, and hospital diet might have been insufficient to provide 
adequate caloric and nutritional intake.  All these factors in addition to the small sample size 
may have compromised the outcome of the study.  
Therefore, if the current study had more control over individual differences and 
nutritional aspects of the program different, perhaps more significant, results could have been 
attained.  Nevertheless, no change in OME suggests that the combined exercise program used 
in this study preserves muscle mass and helps combat muscle wasting effect in acute 
leukemia patients.  Therefore, the maintenance of OME should be seen as a positive outcome 
in the acute leukemia population during treatment.   
 
Decrease in Overall Fatigue 
Another important finding of this study was significant reduction in overall fatigue level 
(p = 0.009), from moderate (4.6) at the beginning of the study to very mild (1.8) upon 
completion of the exercise program, measured by the Revised Piper Fatigue Scale.  These 
results were consistent with the results of many other studies that also reported significant 
decrease in fatigue in response to exercise programs of various designs, modes, intensities, 
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duration, and different types of cancer patients (Adamsen et al., 2003; Battaglini et al., 2006; 
Dimeo et al., 2004; Segal et al., 2003).  Therefore, the results of the current study also 
suggest and agree with previous studies that exercise does assist in reducing fatigue in acute 
leukemia patients undergoing treatment. 
This finding is very important because increase in fatigue has been reported as the most 
prevalent side effect experienced by the cancer patients undergoing chemotherapy (Servaes 
et al., 2002).  It indirectly impacts many physiological systems, and, most important of all, 
contributes to a significant reduction in overall quality of life (Dimeo et al., 1999).  If not 
treated, fatigue can become a chronic condition that is complex and very different from 
fatigue experienced by healthy population.  Fatigue experienced by cancer patients should be 
considered as a multidimensional phenomenon that affects physical, psychological, and even 
social domains of patients’ health (Battaglini et al., 2006; Dimeo, 2001).  Especially in the 
acute leukemia population, the psychological impact of the disease diagnosis and the nature 
of the treatment (high doses of chemotherapy associated with an in-hospital recovery 
protocol) seem to affect them more than other cancer patients recovering outside of the 
hospital.  Leukemia patients are usually restricted to a hospital room for approximately 4 
weeks during the induction phase of treatment, which results in a decrease in physical 
activity.  Such physical inactivity combined with the treatment-related side effects, especially 
increase in fatigue, lead to a severe deconditioning, which negatively impacts many 
physiological and psychological parameters (Battaglini et al., 2006).  This decline in physical 
conditioning can further the fatigue and create a debilitating fatigue cycle, which if not 
treated, could result in further decrease in overall functionality putting limitations on normal 
daily activities and thus decreasing overall quality of life (Battaglini et al., 2006). 
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Thus, significant decrease in overall fatigue observed in this study suggests that exercise 
intervention promotes positive physiological and psychological changes by breaking the 
debilitating fatigue cycle.  Therefore, this result has a significant clinical relevance for acute 
leukemia population undergoing treatment. 
 
Relationship between Changes in Cardiorespiratory Endurance and Fatigue 
According to Hypothesis 4, there would be a significant inverse relationship between 
changes in cardiorespiratory endurance and fatigue from pre-to-post assessments. Significant 
improvements in both, cardiorespiratory endurance and fatigue were observed during the 
study (p = 0.009 for both).  However, no significant relationship was found between the 
change scores of these two variables (r (7) = -0.26, p = 0.534).  The results of regression 
analysis were also non-significant (p = 0.708) and showed that CRE explained only 2.5% of 
the variance in fatigue (Table 9).   
The results of this study are consistent with the results reported by Battaglini et al. 
(2004).  After examining a group of 27 patients of different cancer types, Battaglini et al.  
found no significant relationship between reduction in fatigue and improvement in 
cardiorespiratory fitness measured as total treadmill time (r = 0.001, p = 1.00).  The exercise 
protocol used by Battaglini et al. was similar to the protocol used in present study and also 
included supervised aerobic, resistance, and stretching exercises in a single exercise session.  
In Battaglini et al. study, other physiological parameters were included in a regression model 
such as specific fitness components (total time on a treadmill as measure of cardiorespiratory 
endurance, modified sit-and-reach flexibility test, and % body fat) as well as results of 
specific strength exercises tested during the study (number of repetitions on the chest press, 
leg press, and abdominal exercises).  Battaglini et al. found that when all these fitness 
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parameters were included in a regression model, even though the model presented a not 
significant result (p = 0.351), the researchers found a positive, linear relationship, suggesting 
a possible trend.  The authors suggested that the non-significant findings were due to the 
small sample size and the variability of the sample, composed of patients with different types 
of cancer.  They also suggested that fatigue is multifactorial in cancer patients, and therefore 
not only one physiological parameter, but a combination of many factors impact fatigue in 
cancer patients, suggesting that fatigue should not be treated unidimentionally.  
The trend towards decrease in fatigue with improvement in aerobic fitness was 
observed in other studies (Dimeo et al., 1998; Adamsen et al., 2006).  Dimeo et al. (1998) 
conducted aerobic exercise program with only five cancer patients and reported significant 
improvement in maximal physical performance, measured as maximal walking speed and 
distance covered.  At the same time, all patients experienced reduction in fatigue and could 
perform their normal daily activities without limitations.  A larger study by Adamsen et al. 
(2006) showed that multidimensional exercise program significantly improved 
cardiovascular capacity (VO2max) of eighty-two patients with various cancers, who at the 
same time reported significant reduction in fatigue.  However, no correlation analysis was 
performed in either study to look at the relationship between the changes in these two 
variables. 
In a study conducted by Schwartz (1999), a significant positive relationship was 
found between an increase in fatigue with improvement in cardiorespiratory fitness, 
measured by distance covered in 12-minute walk (r2 = 0.353, p = 0.02).  However, the major 
limitation in Schwartz’s study was that the intervention was unsupervised home-based 
exercise program.  Patients were instructed to exercise at their own pace of preference and 
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were free to choose the type of aerobic activity.  This protocol limits the ability to generalize 
the results of the study and therefore should be viewed with caution.   
The contradictory results of the studies described above may be explained by many 
factors, including differences in exercise protocols (intensity, duration, type of exercise, 
supervised vs. unsupervised, in-hospital vs. home-based, different measures and tests used to 
assess cardiorespiratory fitness, different cancer populations) and conditions in which these 
patients were studied (during the treatment or during the recovery).   
Nevertheless, the majority of the studies have shown significant decreases in fatigue, 
which confirms the positive impact of exercise in assisting cancer patients to battle side 
effects developed during the treatment.  The results of the current study are in agreement 
with Dimeo et al. (1999), where the authors suggested that fatigue should be seen as a 
multifactorial process in the cancer population, and therefore examinations of physiological 
parameters performed independently should be revised.  Even though significant changes in 
cardiorespiratory endurance were observed in the current study, the impact of aerobic, 
resistance and flexibility training on fatigue should be analyzed in combination and not in an 
isolated manner.  Furthermore, psychological support and encouragement from physicians, 
nurses, and exercise trainers during exercise sessions could be considered as an important 
social support component of the therapy, which could have affected the reduction in fatigue 
but not changes in cardiorespiratory endurance observed in the study.  
Therefore, future studies should perform multidimensional analyses, where multiple 
parameters, including some psychosocial ones, are included into a model, so better 
conclusions can be made on the impact of exercise on fatigue reductions.  Since the 
variability within cancer patients is quite large, this approach may also be explored on a case 
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by case basis, where specific conclusions can be made to each patients individually.  Baseline 
measures of all these parameters may be used to define more specific treatment plans. 
  
Relationship between Changes in Overall Muscular Endurance and Fatigue 
Similar to Hypothesis 4, Hypothesis 5 stated that there would be a significant reverse 
relationship between changes in overall muscular endurance (OME) and fatigue from pre-to-
post assessments.  Results of correlation analysis again showed no significant relationship 
between change scores of OME and fatigue (r (7) = -0.335, p = 0.417) with OME explaining 
only 1.3% of the variance in fatigue, according to non-significant results of regression 
analysis (p = 0.79).  Despite the lack of statistical significance, the results of the current study 
are again consistent with those reported by Battaglini et al. (2004).   
In the contrast, two other studies showed significant reduction in fatigue with 
improvements in overall muscular strength (Adamsen et al., 2006; Segal et al., 2003).  The 
study by Adamsen et al. (2006) showed that, along with improvements in cardiorespiratory 
fitness, multidimensional exercise program significantly improved overall muscular strength 
and resulted in a significant reduction in fatigue.  Segal et al. (2003) conducted 12-week 
whole body resistance training and showed significant improvement in overall body strength 
with significant decrease in fatigue.  However, the sample size in both studies was large (n = 
82, n = 155) suggesting higher statistical power.  Again, no correlation analysis of the 
relationship between the changes in the two variables was performed in either study.    
The results of the analyses of hypothesis 5 of the current study suggest again using the 
multidimensional approach when measuring fatigue.  Therefore, overall muscular endurance 
should not be used in regression analysis separately from other physiological and 
psychological parameters. 
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Other Factors that Could Have Impacted the Study Results 
The non-significant results of correlation between changes in physical fitness parameters 
and fatigue could possibly be attributed to the following additional factors. 
First, the study was a one-group pre-to-post design, not a randomized controlled study, in 
which the results are compared to the control group, thus improving the power of the 
analyses.  For example, using a control-group design and aerobic exercise program Dimeo et 
al. (1999) found no change in fatigue in the exercise group, while patients in the control 
group showed significant increase in fatigue and reduction in vigor. 
Second, as already mentioned above, the small sample size (n = 8) may have resulted in 
low statistical power of regression analyses, which was one of the major limitations of the 
current study.  Other potential factors, including inability to control for differences in age, 
gender and fitness levels that together contributed to the large variability of the sample, are 
discussed below.  
The presence of two outliers (a very fit person and a very unfit person) out of 8 subjects 
greatly increased variability of the sample and affected the power of the statistical analyses 
(large standard deviations in both cardiorespiratory and muscular endurance).  In healthy 
populations, individuals with low initial levels of fitness generally demonstrate the greatest 
increase in cardiorespiratory capacity (ACSM’s Guidelines, 2006).  In contrast, more modest 
increases occur in healthy individuals with high initial fitness levels.  Similarly, a great 
variability in subjects’ fitness level resulted in a large variability in the responses (change 
scores) to the exercise program.  For example, on average leukemia patients showed about 8 
minutes improvement in total time of cycling (the mean for the change score of 
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cardiorespiratory endurance was 8.07 minutes and SD was 6.42 minutes) while the individual 
improvements varied from 0 to 17 minutes.  
In addition, the gender differences (2 females and 6 males) and a wide range of patients’ 
age in this study (24 to 48 years old) might have also increased the variability in the 
responses to the exercise program.  According to ACSM’s guidelines (2006) women 
generally have lower physiological responses to a same exercise program than men, 
especially when resistance exercise is included into a program.  Similarly, older adults (for 
example, over 40 years old in this study) are usually shown to have lower responses when 
compared to younger adults (24-28 years in the current study).  Unfortunately, due to a small 
sample size in this study it was not possible to control for either age or gender.  Thus, all of 
the above factors could have affected the statistical power compromising the regression 
analysis.   
At last, as mentioned previously in the document, fatigue is believed to be 
multidimensional phenomena that have physical as well as psychological and even social 
components in it (Battaglini et al., 2006; Dimeo, 2001).  When fatigue is measured, using 
Revised Piper Fatigue Scale (Piper et al., 1998), the physical domain is not addressed to the 
same extend of the psychological and social domains (behavioral, emotional, sensory, and 
cognitive) where only 6 out of 27 questions of the instrument are related to physical fatigue.  
This study utilized Revised Piper Fatigue Scale and examined the relationship between 
overall fatigue and physiological parameters, and not psychological or social ones.  In a 
related study, Dimeo et al. (1997) found a strong correlation between intensity of fatigue and 
several indicators of psychological distress such as depression (r = 0.68) and anxiety (r = 
0.63; p < 0.001 for both), while only a weak association between fatigue and physical 
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performance (estimated VO2max) was observed (r = -0.30; P < 0.01).  Thus, a non-significant 
relationship between changes in physical fitness parameters and fatigue found in the current 
study may also be explained by the multidimensional nature of treatment-related fatigue and 
by limitations of the instrument used to measure fatigue. 
 
Conclusion 
Exercise has been shown to be a promising adjunct therapy to cancer treatment.  Many 
studies have reported numerous benefits of exercise to cancer patients, including positive 
changes in physiological parameters such as cardiorespiratory endurance, muscular 
endurance, flexibility, overall functionality, as well as psychological parameters such as 
reductions in depression, fatigue, and anxiety and improvement in overall quality of life 
(Galvao and Newton, 2005).  
Up to now, most of the studies in area of cancer and exercise have focused on breast and 
prostate types of cancer.  Present study was the first to explore the effect of individually 
prescribed exercise program in adult acute leukemia population undergoing chemotherapy.  
The results of the current study are in agreement with the majority of the studies where 
improvements in many physiological and psychological parameters were observed. 
 In conclusion, the results of the current study suggest that the administration of exercise 
for acute leukemia patients undergoing chemotherapy (induction phase of treatment) is 
feasible, well tolerated by patients, promoting increase in cardiorespiratory endurance, 
maintenance of overall muscular endurance, while reducing the level of fatigue.    
Even though there were limitations believed to have impacted some of the study analyses, 
the overall outcomes of the exercise intervention used in the current study are very promising 
and should encourage physicians and researchers to continue to explore the impact of 
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exercise in the acute leukemia population.  Although adjustment in the methodology of the 
current study should be considered for future experiments, the current study should be used 
as a starting point for future research in this area. 
 
Recommendations 
Based on the results of this study and limitations observed, the following are 
recommendations for future research in the area of cancer and exercise, specifically related to 
acute leukemia population: 
1. A further randomized controlled study with a larger sample size is needed to increase 
statistical power of the analysis and credibility of the results; 
2. Control for individual differences in age, gender and fitness level may be valuable to 
examine if any of these factors affect the outcomes of the exercise program during 
leukemia treatment. A larger sample size in this case will be necessary.  
3. When creating an overall muscular endurance protocol there is also a need to improve 
the upper body resistance training while patient has a chemotherapy port inserted; 
4. Achieve a better control over unsupervised portion of the exercise program (during 2-
week recovery phase); 
5. Explore the possibility of creating a better measurement of fatigue that takes into 
consideration some physiological parameters; 
6. Include assessment of psychological parameters such as anxiety, depression and 
motivation in future studies to better understand the psychological mechanisms 
affecting patients’ health status and outcomes of an exercise intervention; 
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7. The implementation of recreation therapy and nutritional counseling in addition to 
combined exercise protocol, as a mean of improving both the physiological and 
psychological aspects of the patients’ health during treatment; 
8. Provide education for leukemia patients to prepare them to deal with side effects and 
different issues of the treatment and disease itself, as well as education on exercise 
benefits for leukemia population; 
9. If possible to extend the duration of the program including the consolidation portion 
of the treatment plan to promote further benefits of exercise for acute leukemia 
population;  
10. Follow up studies should be done in the future to examine the long-term impact of the 
exercise intervention on leukemia re-occurrence and survivorship rates. 
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APPENDIX II: 
 
The EQUAL Project 
Pre-Assessment Guidelines 
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The EQUAL Project 
(Exercise and Quality of Life in Leukemia/ Lymphoma Patients) 
 
 
Pre-Assessment Guidelines 
. 
 
• Wear comfortable clothing, socks, and athletic shoes if available. 
o Women: Wear a loose-fitting, short-sleeved blouse that buttons down the 
front. Also, avoid restrictive undergarments. 
• Drink plenty of fluids (water or sports drink) during the 24-hour period before the 
test. 
• Refrain from eating, smoking, and drinking alcohol or caffeine for 3 hours prior to the 
test. 
• Do not engage in any physical activity the day of the test. 
• Get adequate sleep (6 or more hours) the night before the test. 
• Continue taking any medications on their usual schedule so that the exercise 
responses will be consistent with responses during exercise training. 
 
 
ACSM’s Guidelines for Exercise Testing and Prescription, 7th Edition, 2006, p. 53-54. 
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APPENDIX III: 
 
Revised Piper Fatigue Scale 
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APPENDIX IV: 
 
BORG CR10 Rate of Perceived Exertion (RPE) Scale 
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BORG CR10 Rate of Perceived Exertion (RPE) Scale 
 
 
0   Nothing at all   No Intensity 
 
0.3     
    
0.5   Extremely weak   Just noticeable 
 
0.7     
 
1   Very weak 
 
1.5     
 
2   Weak              Light 
 
2.5 
 
3   Moderate    
 
4     
 
5   Strong    Heavy 
 
6 
 
7   Very strong 
 
8  
 
9 
 
10   Extremely strong            Strongest intensity 
 
11 Absolute max exertion             Highest Possible 
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APPENDIX V: 
 
Dynamic Muscular Endurance Test 
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Dynamic Muscular Endurance Test 
(Biceps exercise) 
(Rocky Mountain Cancer Rehabilitation Institute Protocol) 
 
Patients will execute repetitions until RPE of 7 is reached during the bicep curl exercise 
using a predetermined % of their body weight calculated according to their age and sex. See 
Below 
 
 
Formula to determine “weight to be lifted”: 
 
BW x Protocol Percentage (constant for the exercise) = Exercise Load 
 
Where:  
BW = Patient Body Weight 
Protocol Percentage = (% body weight to be lifted)  
Age:  < 45  
Men (Right and Left Arm)            Women (Right and Left Arm) 
.085          .065 
  
Age:  45 - 60  
Men (Right and Left Arm)            Women (Right and Left Arm) 
.080          .061 
 
Exercise Load =  “weight to be lifted” 
 
Example:  45 years old male, 150lbs. 
Bicep Curl (right arm) =  150 x .080 =  12lbs (“weight to be lifted) 
 
Important considerations: 
 
1) Ensure that subjects are properly "warmed-up" before initiation of the test protocol. 
2) Patients should perform as many complete repetitions as possible, until an RPE of 7 is 
reached. 
3) Compute "weight to be lifted" according to the age, sex, and body weight specifications 
outlined. 
4) Assist the client with the 1st repetition and then continue to "spot" 
throughout the test. 
5) Repetitions should be performed at a controlled cadence ("1, 2, 3" - Up, "1, 2, 3" - Down). 
 
 
 
Rocky Mountain Cancer Rehabilitation Institute 
Ben Nighthorse Campbell Center 19th St. at 10th Ave. 
Greeley, Colorado 80639 
Phone 970-351-1876 
67  
REFERENCES 
 
Adamsen, L., Quist, M., Midtgaard, J. et al. (2006) The effect of a multidimensional exercise 
intervention on physical capacity, well-being and quality of life in cancer patients 
undergoing chemotherapy. Support Care Cancer, 14(2), 116-127. 
Al-Majid, S. and D.O. McCarthy (2001) Cancer-induced fatigue and skeletal muscle wasting: 
The role of exercise. Biological Research for Nursing, 2(3), 186-197. 
American Cancer Society. Cancer facts and figures, 2006. Retrieved November 10, 2006 
from http://www.cancer.org 
American College of Sport Medicine. ACSM’s Guidelines for exercise testing and 
prescription (2006). (7th ed.) Baltimore: Lippincott Williams & Wilkins. 
Battaglini, C., Dennehy, C., Groff, D. et al. (2006) Complimentary therapies in the 
management of cancer treatment-related symptoms: the individualized prescriptive 
exercise intervention approach. Medicina Sportiva, 10(2), 49-57. 
 
Borg, G. (1998) Borg’s Perceived Exertion and Pain Scales. Champaign: Human Kinetics.  
Courneya, K.S., Friedenreich, C.M., Quinney, H.A. et al. (2003) A randomized trial of 
exercise and quality of life in colorectal cancer survivors. European Journal of 
Cancer Care (Engl), 12(4), 347-57. 
Courneya, K.S., Keats, M.R., Turner, A.R. et al. (2000) Physical exercise and quality of life 
in cancer patients following high dose chemotherapy and autologous bone marrow 
transplantation. Psychooncology, 9(2), 127-36. 
Cunningham A.J., Morris G., & Cheney C.L. (1986) Effects of resistance exercise on skeletal 
muscle in marrow transplant recipients receiving total parental nutrition. Journal of 
Parenteral and Enteral Nutrition, 10, 558-563. 
Dimeo, F.C. (2001) Effects of exercise on cancer-related fatigue. Cancer, 92, 1689-1693. 
Dimeo, F.C., Rumberger, B.G., Keul, J. (1998) Aerobic exercise as therapy for cancer 
fatigue. Medicine and Science in Sports and Exercise, 30, 475-478. 
Dimeo, F.c., Schwartz S., Fietz, T. et al. (2003) Effects of endurance training on the physical 
performance of patients with hematological malignancies during chemotherapy. 
Support Care Cancer, 11, 623-628. 
Dimeo, F.C., S A. Schmittel, T. Fietz et al. (2004) Physical performance, depression, 
immune status and fatigue in patients with hematological malignancies after treatment 
Annals of Oncology, 15, 1237-1242. 
68  
Dimeo, F.C., Stieglitz,, R.D., Novelli-Fischer, U. et al. (1997) Correlation between physical 
performance and fatigue in cancer patients. Annals of Oncology, 8, 1251-1255. 
Dimeo, F.C., Stieglitz, R.D., Novelli-Fischer, U. et al. (1999) Effects of physical activity on 
the fatigue and psychological status of cancer patients during chemotherapy. Cancer, 
85, 2273-2277. 
Galvão, D.A. & Newton, R.U. (2005) Review of exercise interventions studies in cancer 
patients. Journal of Clinical Oncology, 23(4), 899-909. 
Hemming L. and D. Maher (2005) Understanding cachexia and excessive weight loss in 
cancer. British Journal of Community Nursing, Nov 10(11), 492-5. 
Kolden, G.G., Strauman, T.J., Ward, A., et al. (2002) A pilot study of group exercise training 
(GET) for women with primary breast cancer: Feasibility and health benefits. 
Psychooncology, 11, 447-456. 
Leukemia and Lymphoma Society. Leukemia, Lymphoma, Myeloma, Facts 2006-2007. 
Retrieved November 10, 2006 from http://www.leukemia-lymphoma.org 
Lucia, A., Ramirez, M., San Juan, A.F. et al. (2005) Intrahospital supervised exercise 
training: a complimentary tool in the therapeutic armamentarium against childhood 
leukemia. Leukemia, 19, 1334-1337. 
Marchese, V.G., Chiarello, L.A. & B.J. Lange (2004) Effects of physical therapy intervention 
for children with acute lymphoblastic leukemia. Pediatric Blood and Cancer, 42,  
127−133.30.  
National Cancer Institute. SEER Cancer Statistics Review, 1975-2003. Retrieved November 
10, 2006 from http://seer.cancer.gov/csr/1975_2003 
 
Piper, B.F., Dibble, S.L., Dodd, M.J., Weiss, M.C., Slaughter, R.E. & Paul, S.M. (1998) The 
revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. 
Oncology Nursing Forum, 25(4):677-84. 
Segal, R., Evans, W., Johnson, D., et al. (2001) Structured exercise improves physical 
functioning in women in stages I and II breast cancer: Results of a randomized 
controlled trial. Journal of Clinical Oncology, 19, 657-665. 
Segal, R., Reid, R., Courneya, K., et al. (2003) Resistance exercise in men receiving 
androgen deprivation therapy for prostate cancer. Journal of Clinical Oncology, 21, 
1653-1659. 
Servaes, P., Verhagen, C., Bleijenberg, G. (2002) Fatigue in cancer patients during and after 
treatment: prevalence, correlates and interventions. European Journal of Cancer, 
38(1), 27-43. 
69  
Shore, S. & R.J. Shepard (1999)  Immune responses to exercise in children treated for cancer. 
The Journal of Sports Medicine and Physical Fitness, 39, 240−243.  
Schwartz, A.L. (1999) Fatigue mediates the effects of exercise on quality of life. Quality of 
Life Research, 8, 529-538. 
Winningham, M.L. (2001) Strategies for managing cancer-related fatigue syndrome: a 
rehabilitation approach. Cancer, 92(4 Suppl), 988-997. 
Winningham, M.L., MacVicar, M.G., Bondoc, M., et al. (1989) Effects of aerobic exercise 
on body weight and composition in patients with breast cancer on adjuvant therapy. 
Oncology Nursing Forum, 16, 683-689. 
